Loading insider details...
Beta
Latest Form 4 (Sep 2, 2026): Grant/Award of 1,633 INKT shares, $17.9K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 2, 2026 | MiNK Therapeutics, Inc. (INKT) | Grant/Award | 1,633 | $17.9K |
| Aug 11, 2026 | AGENUS INC (AGEN) | Grant/Award | 100,000 | n/a |
| Jun 2, 2026 | MiNK Therapeutics, Inc. (INKT) | Grant/Award | 1,640 | $17.9K |
| Apr 28, 2026 | AGENUS INC (AGEN) | Grant/Award | 210,000 | n/a |
| Jan 6, 2026 | MiNK Therapeutics, Inc. (INKT) | Grant/Award | 5,395 | n/a |
| Dec 3, 2025 | MiNK Therapeutics, Inc. (INKT) | Grant/Award | 1,612 | $17.9K |
| Sep 11, 2025 | MiNK Therapeutics, Inc. (INKT) | Grant/Award | 3,225 | n/a |
| Sep 3, 2025 | MiNK Therapeutics, Inc. (INKT) | Grant/Award | 1,290 | $17.9K |
| Jun 20, 2025 | AGENUS INC (AGEN) | Grant/Award | 750 | n/a |
| Jun 4, 2025 | MiNK Therapeutics, Inc. (INKT) | Grant/Award | 2,494 | $17.9K |